BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Wang H, Ricketts CJ, Yang Y, Merino MJ, Zhang H, Shi G, Gan H, Linehan WM, Zhu Y, Ye D. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease. Cancer 2019;125:1060-9. [PMID: 30548481 DOI: 10.1002/cncr.31908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Han S, Camp SY, Chu H, Collins R, Gillani R, Park J, Bakouny Z, Ricker CA, Reardon B, Moore N, Kofman E, Labaki C, Braun D, Choueiri TK, AlDubayan SH, Van Allen EM. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma. medRxiv 2023:2023. [PMID: 36712083 DOI: 10.1101/2023.01.18.23284664] [Reference Citation Analysis]
2 Wu J, Jin S, Gu C, Wei Y, Zhu Y, Necchi A, Shariat SF, Pan J, Gan H, Dai B, Zhang H, Shi G, Zhu Y, Shen Y, Zhu Y, Ye D. Inherited mutations in Chinese patients with upper tract urothelial carcinoma. Cell Rep Med 2023;4:100883. [PMID: 36630951 DOI: 10.1016/j.xcrm.2022.100883] [Reference Citation Analysis]
3 Pan J, Zhao J, Ni X, Gan H, Wei Y, Wu J, Zhang T, Wang Q, Freedland SJ, Wang B, Song S, Ye D, Liu C, Zhu Y. The prevalence and prognosis of next-generation therapeutic targets in metastatic castration-resistant prostate cancer. Mol Oncol 2022;16:4011-22. [PMID: 36209367 DOI: 10.1002/1878-0261.13320] [Reference Citation Analysis]
4 Onal B, Gultekin MH, Simsekoglu MF, Selcuk B, Gurbuz A. Biomarkers in Urological Cancers. Biomarkers in Medicine 2022. [DOI: 10.2174/9789815040463122010005] [Reference Citation Analysis]
5 Li H, Yang W, Tu X, Yu L, Huang D, Cheng Y, Chang B, Tang S, Ge H, Bao L, Zhou X, Bi R. Clinicopathological and molecular characteristics of fumarate-hydratase-deficient uterine smooth muscle tumors: A single-center study of 52 cases. Hum Pathol 2022:S0046-8177(22)00138-1. [PMID: 35659509 DOI: 10.1016/j.humpath.2022.05.016] [Reference Citation Analysis]
6 Lin F, Li X, Wang X, Sun H, Wang Z, Wang X. Stanniocalcin 1 promotes metastasis, lipid metabolism and cisplatin chemoresistance via the FOXC2/ITGB6 signaling axis in ovarian cancer. J Exp Clin Cancer Res 2022;41:129. [PMID: 35392966 DOI: 10.1186/s13046-022-02315-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kong W, Yang T, Wen X, Mu Z, Zhao C, Han S, Tian J, Zhang X, Zhou T, Zhang Y, Lou F, Cao S, Wang H, Zhang J. Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma. Front Oncol 2021;11:737547. [PMID: 34926252 DOI: 10.3389/fonc.2021.737547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Truong H, Sheikh R, Kotecha R, Kemel Y, Reisz PA, Lenis AT, Mehta NN, Khurram A, Joseph V, Mandelker D, Latham A, Ceyhan-Birsoy O, Ladanyi M, Shah NJ, Walsh MF, Voss MH, Lee CH, Russo P, Coleman JA, Hakimi AA, Feldman DR, Stadler ZK, Robson ME, Motzer RJ, Offit K, Patil S, Carlo MI. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing. Eur Urol Oncol 2021:S2588-9311(21)00180-2. [PMID: 34654685 DOI: 10.1016/j.euo.2021.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Tian S, Sun S, Mao W, Qian S, Zhang L, Zhang G, Xu B, Chen M. Development and Validation of Prognostic Nomogram for Young Patients with Kidney Cancer. Int J Gen Med 2021;14:5091-103. [PMID: 34511991 DOI: 10.2147/IJGM.S331627] [Reference Citation Analysis]
10 Yu Y, Zheng M, Zhu W, Zhao F, Guan B, Shen Q, Yang F, He Q, Li X. Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature. Urol Oncol 2021;39:791.e9-791.e16. [PMID: 34462205 DOI: 10.1016/j.urolonc.2021.07.026] [Reference Citation Analysis]
11 Abou Alaiwi S, Nassar AH, Adib E, Groha SM, Akl EW, McGregor BA, Esplin ED, Yang S, Hatchell K, Fusaro V, Nielsen S, Kwiatkowski DJ, Sonpavde GP, Pomerantz M, Garber JE, Freedman ML, Rana HQ, Gusev A, Choueiri TK. Trans-ethnic variation in germline variants of patients with renal cell carcinoma. Cell Rep 2021;34:108926. [PMID: 33789101 DOI: 10.1016/j.celrep.2021.108926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
12 Walpole S, Hayward NK, Pritchard AL, Johansson PA. Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in BAP1 Pathogenic Variant Carriers. JCO Clin Cancer Inform 2021;5:143-54. [PMID: 33513031 DOI: 10.1200/CCI.20.00124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Santos M, Lanillos J, Roldan-romero JM, Caleiras E, Montero-conde C, Cascón A, Climent MA, Anguera G, Hernando S, Laínez N, Robledo M, Robles L, de Velasco G, García-donas J, Rodriguez-antona C. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma. Genet Med 2021;23:698-704. [DOI: 10.1038/s41436-020-01062-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Smith S, Abdel-rahman MH, Pilarski R, Davidorf FH, Cebulla CM. BAP1 Tumor Predisposition Syndrome. Uveal Melanoma 2021. [DOI: 10.1007/978-3-030-78117-0_3] [Reference Citation Analysis]
15 Wan P, Chen Z, Zhong W, Jiang H, Huang Z, Peng D, He Q, Chen N. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma. Oncol Rep 2020;44:2475-86. [PMID: 33125143 DOI: 10.3892/or.2020.7796] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Meng H, Jiang X, Cui J, Yin G, Shi B, Liu Q, Xuan H, Wang Y. Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma. Biomed Res Int 2020;2020:2495157. [PMID: 33062672 DOI: 10.1155/2020/2495157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
17 Smith PS, West H, Whitworth J, Castle B, Sansbury FH, Warren AY, Woodward ER, Tischkowitz M, Maher ER. Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity. Genes Chromosomes Cancer 2021;60:5-16. [PMID: 32830346 DOI: 10.1002/gcc.22893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Mikhaylenko DS, Tanas AS, Zaletaev DV, Nemtsova MV. Application Areas of Traditional Molecular Genetic Methods and NGS in relation to Hereditary Urological Cancer Diagnosis. J Oncol 2020;2020:7363102. [PMID: 32612654 DOI: 10.1155/2020/7363102] [Reference Citation Analysis]
19 Jiangyi W, Gang G, Guohai S, Dingwei Y. Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients. Aging (Albany NY) 2020;12:756-66. [PMID: 31927531 DOI: 10.18632/aging.102654] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]